LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 140 pages found matching zyprexa- Risperdal, Atypical Antipsychotic, Linked to Fractures in Seniors
Jan-22-15 Toronto, Canada A new study by researchers in Canada suggests that atypical antipsychotic medications such as Risperdal may have side effects that include a risk of falling and a risk of fractures. The study, which was published online in JAMA Internal Medicine (1/12/15) found that seniors aged 65 and older who were newly taking atypical antipsychoti... - All Eyes on Philadelphia and Pending Trial for Risperdal and Growing Male Breasts
Oct-29-14 Philadelphia, PA A study appearing this month in the Journal of Clinical Psychopharmacology suggests that Americans treated with the antipsychotic risperidone (Risperdal) presented with a 69 percent increased risk for the development of Risperdal gynecomastia when compared against those who did not take Risperdal. Gynecomastia is the growth of mal... - Canadian Attorney Files DePuy Class Action
Jan-11-11 Toronto, Ontario In early December 2010, Colin Stevenson of Stevensons LLP, a Canadian law firm based in Toronto, filed a products liability class-action lawsuit against Johnson & Johnson and its DePuy Orthopaedics subsidiary. Mr. Stevenson discusses the Canadian Depuy lawsuit with LawyersandSettlements. Q: (LawyersandSettlements) This Canadi... - Better than Byetta?
Sep-14-10 Washington, DC Do pharmaceutical companies make drugs to make us well, or simply to make money? Eli Lilly and Co. is currently waiting for a Food and Drug Administration (FDA) decision on a longer-acting version of its diabetes drug Byetta , which it partners on with Amylin Pharmaceuticals Inc. The patent for Byetta expires in 2013, according to a Ci... - Qui Tam Whistleblower Off-label Pharma Suits on the Rise
May-14-10 Washington, DC Pharmaceutical and medical device companies are likely rethinking their fraudulent marketing plans, thanks to a number of successful qui tam off-label lawsuits that have cost pharma companies billions of dollars and reaped substantial awards for whistleblowers. Off-label use of a drug or device is a use other than that for which the p... - Hydroxycut Litigation Starts Packing On Heavyweight Attorneys
May-29-09 Hackensack, NJ: Balkin & Eisbrouch have been hammering away in the mass torts field for more than a decade and it shows. The list of dangerous drugs alone that David Eisbrouch has worked on literally goes from A to Z. From Accutane to Zyprexa, Eisbrouch has represented hundreds, if not thousands of people and won significant awards on behalf his clients. A... - Psychiatric Drugging of Children Intolerable-Betrayal of Innocence
Mar-8-09 Washington, DC The following is the third and final article in the series Psychiatric Drugging of Children . Part 2 explains how a -year-old girl named Rebecca Riley died of an overdose after being diagnosed with ADHD and bipolar disorder by Dr Kayoko Kifuji, at Tufts New England Medical Center in Boston, and placed on a three-drug cocktail.... Reb... - Psychopharmacology In Court
Jul-29-08 A previously outgoing, athletic and scholastically proficient 12 year-old begins to show increasing academic problems. Over the course of 18 months, he is treated by HMO pediatricians and child psychiatrists for ADD (Attention Deficit Disorder) to which the diagnosis of Oppositional Defiant Disorder and Bipolar Disorder are progressively added on. He i... - Trasylol Fiasco - FDA Fails To Protect Americans Again - Part I
Feb-1-08 Washington, DC: On November 5, 2007, the FDA announced that Bayer Pharmaceuticals had suspended the marketing of Trasylol after preliminary results of a Canadian study indicated that patients may also have a greater risk of death than patients taking either of two other drugs. The Canadian study, Blood Antifibrinolytics Randomized Trial (BART), led... - FDA Wakes Up: Now Requires Drug Makers to Test for Suicide
Jan-24-08 Washington, DC: Although there is no direct reference to Chantix, the smoking cessation drug that has been the center of much recent concern regarding suicidal thoughts, the US Food and Drug Administration (FDA) has just announced a policy that requires drug manufacturers to study the potential for suicidal tendencies during clinical trials. In the pa... - World Experts Demand End to Child Drugging in the US - Part I
Oct-25-07 Washington, DC: On October 12, 2007, experts in the field of psychiatry and child development from all over the world arrived in Washington to attend the annual conference of the International Center for the Study of Psychiatry and Psychology. This year's conference focused on one specific goal - to end the mass-prescribing of psychiatric drugs to children... - More Seroquel Lawsuits: Patients Speak Out
Jul-15-07 Wilmington, DE Patients are speaking out about their experiences with the controversial anti-psychotic drug Seroquel , as lawsuits against AstraZeneca, the drug's maker, are on the rise. Legal actions started when the FDA ordered a label change several years ago, indicating patients are at a heightened risk of contracting diabetes and other blood sugar... - J&J Concealed Dangers of Ortho Evra Birth Control Patch
Apr-16-07 Washington, DC: Tens of millions of prescriptions have been written for Johnson & Johnson's Ortho Evra birth control patch since it arrived on the market in 2002, and medical experts say the patch has harmed thousands of young women of childbearing age. In September 2006, the FDA warned that use of the patch, made by the Ortho-McNeil division of J&J,... - Investigators Zero In on Pill Pushing Doctors
Mar-14-07 Washington, DC: The number one goal of drug makers in dispatching sales representatives to meet with doctors face-to-face is to increase sales by convincing doctors to prescribe drugs off-label for unapproved uses, by saying whatever it takes to achieve that goal. A May 2006, study titled, "Turning Medicine Into Snake Oil," analyzed FDA warning letters... - Drug Makers Trolling for Infants and Toddlers
Dec-21-06 The motive behind Big Pharma's promotion of the off-label prescribing of psychotropic drugs is market expansion and unfortunately, it just so happens that children provide the richest harvest because most kids are covered by health insurance plans or Medicaid. The various recruitment schemes include trolling for customers among infants and toddlers betwee... - TeenScreen - Prescription Drug Pusher In Schools
Jul-17-06 Whenever a TeenScreen article appears in the mainstream media, it never discusses the fact that the survey is being used to label children with any number of mental illnesses. The point needs to be made that this so-called "suicide prevention tool" has a lofty purpose alright, but caring about whether or not kids commit suicide ain't it. According to atto... - Lawsuits - Only Weapon Available Against Giant Big Pharma Pushers
Jul-11-06 Over the past several years, new studies have shown the new generation of psychiatric drugs to be not only extremely dangerous but also ineffective, and the majority of these medications in fact now carry black box warnings about a number of life-threatening side effects associated with their use. The drugs include selective serotonin re-uptake inhibitor... - Big Pharma Research Racket Is Killing People
Jun-23-06 Over the past six years, ten FDA approved drugs have been withdrawn from the market due to deaths and injuries, leading lawmakers to accuse the FDA of not doing its job in protecting the public from unsafe drugs and to call for measures of improvement. On June 20, 2006, the New York Times reported that "two influential senators are expected within weeks t... - Legal ADHD Speed - Becoming Drug Of Choice For Americans
Mar-21-06 A study published online in the February 2006, Journal of Drug and Alcohol Dependence, that examined data from a 2002 survey of about 67,000 households, estimates that more than 7 million Americans have misused stimulant drugs meant to treat ADHD, and "substantial numbers of teenagers and young adults appear to show signs of addiction, according to a compreh... - Psych Drugs - Doctors Serve As Middle-Man Pushers
Feb-21-06 Although peddling psychiatric drugs for off-label treatment of every ailment known to man is highly profitable, it is also illegal. Marketing schemes that increase the rates at which drugs are prescribed for off-label use, result in the sale of drugs that have not been proven safer or superior to FDA approved medications already on the market. That said,...